Literature DB >> 8735114

Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.

J Berenguer1, T M Diaz-Guerra, B Ruiz-Diez, J C Bernaldo de Quiros, J L Rodriguez-Tudela, J V Martinez-Suarez.   

Abstract

We describe a patient with AIDS who simultaneously developed Candida meningitis with three positive cerebrospinal fluid cultures and oral candidiasis. This patient also had a history or recurrent episodes of oral candidiasis treated with fluconazole. The patient did not respond to this therapy but was cured with amphotericin B and flucytosine. In vitro susceptibility tests revealed that each infection was caused by fluconazole-resistant Candida albicans isolates. Strain delineation by karyotyping, NotI restriction pattern analysis, hybridization with the specific probe 27A, and PCR fingerprinting with the phage M13 core sequence clearly demonstrated that meningitis and oral thrush were caused by two genetically different isolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735114      PMCID: PMC229058          DOI: 10.1128/jcm.34.6.1542-1545.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  Epidemiology of fungal infections: the promise of molecular typing.

Authors:  M A Pfaller
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

2.  Spontaneous Candida albicans meningitis in a patient with the acquired immune deficiency syndrome.

Authors:  W F Ehni; R T Ellison
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

3.  A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA.

Authors:  G Vassart; M Georges; R Monsieur; H Brocas; A S Lequarre; D Christophe
Journal:  Science       Date:  1987-02-06       Impact factor: 47.728

4.  Candida albicans meningitis in a parenteral drug abuser.

Authors:  H L Kantor; H A Emsellem; J E Hogg; G L Simon
Journal:  South Med J       Date:  1984-03       Impact factor: 0.954

5.  In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.

Authors:  J Berenguer; V Fernández-Baca; R Sánchez; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

6.  Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

Authors:  J L Rodríguez-Tudela; J V Martínez-Suárez; F Dronda; F Laguna; F Chaves; E Valencia
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

7.  Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.

Authors:  J L Rodriguez-Tudela; J V Martinez-Suárez
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

8.  Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.

Authors:  A Espinel-Ingroff; J L Rodríguez-Tudela; J V Martínez-Suárez
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis.

Authors:  R A Smego; J R Perfect; D T Durack
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

10.  Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.

Authors:  J V Martinez-Suarez; J L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  9 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates.

Authors:  P Steffan; J A Vazquez; D Boikov; C Xu; J D Sobel; R A Akins
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

3.  Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.

Authors:  T M Díaz-Guerra; J V Martínez-Suárez; F Laguna; J L Rodríguez-Tudela
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

Authors:  S A Yoon; J A Vazquez; P E Steffan; J D Sobel; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Molecular tracking of Candida albicans in a neonatal intensive care unit: long-term colonizations versus catheter-related infections.

Authors:  B Ruiz-Diez; V Martinez; M Alvarez; J L Rodriguez-Tudela; J V Martinez-Suarez
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode.

Authors:  K Vargas; S A Messer; M Pfaller; S R Lockhart; J T Stapleton; J Hellstein; D R Soll
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.

Authors:  J A Vazquez; M T Arganoza; D Boikov; S Yoon; J D Sobel; R A Akins
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens.

Authors:  D Metzgar; A van Belkum; D Field; R Haubrich; C Wills
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  Survey of the Antibiofilm and Antimicrobial Effects of Zingiber officinale (in Vitro Study).

Authors:  Marzieh Aghazadeh; Abed Zahedi Bialvaei; Mohammad Aghazadeh; Fahimeh Kabiri; Negar Saliani; Mehdi Yousefi; Hosein Eslami; Hossein Samadi Kafil
Journal:  Jundishapur J Microbiol       Date:  2016-02-07       Impact factor: 0.747

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.